Position history for Walleye Capital LLC's holdings in REGENERON PHARMACEUTICALS
Walleye Capital LLC holds 4,022 shares of REGN (REGENERON PHARMACEUTICALS), worth $3.1M as of 2026-Q1. The position was decreased (-88.7% shares). REGN represents 0.0% of Walleye Capital LLC's portfolio.
Current Value
$3.1M
Current Shares
4,022
Total Value Change
-$2M
Total Shares Change
-878
Other major holders of REGN: VANGUARD GROUP INC, BlackRock Finance, Inc.
Decreased |
| 4,022 |
-88.7% |
| $3.1M |
| 0.0% |
| $766.66 |
0 |
| 2025-Q4 | Decreased | 35,500 | -59.4% | $27.4M | 0.1% | $773.94 | 0 |
| 2025-Q3 | Increased | 87,474 | +41.6% | $49.2M | 0.2% | $560.05 | 47 |
| 2025-Q2 | Increased | 61,771 | +653.7% | $32.4M | 0.1% | $519.56 | 56 |
| 2025-Q1 | Decreased | 8,196 | -18.6% | $5.2M | 0.0% | $634.66 | 0 |
| 2024-Q4 | Increased | 10,074 | +38.6% | $7.2M | 0.0% | $698.71 | 36 |
| 2024-Q3 | Increased | 7,267 | +48.3% | $7.6M | 0.0% | $1,036.94 | 38 |
| 2024-Q2 | Increased | 4,900 | +9.5% | $5.2M | 0.0% | $1,045.23 | 30 |